FDA approval of drug to prevent preemies prompts price jump from $10 to $1,500

March 29, 2011

In addition to making the drug unaffordable for some women, experts fret about the added costs for insurers that choose to pay for it, especially Medicaid programs already being slashed in states struggling with deficits. (The Washington Post)